SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000902664-19-003718
Filing Date
2019-09-16
Accepted
2019-09-16 08:05:46
Documents
8
Effectiveness Date
2019-09-16

Document Format Files

Seq Description Document Type Size
1 p19-1924dfan14a.htm DFAN14A 59058
2 GRAPHIC image_002.jpg GRAPHIC 102059
3 GRAPHIC image_003.jpg GRAPHIC 66664
4 GRAPHIC image_004.jpg GRAPHIC 62659
5 GRAPHIC image_005.jpg GRAPHIC 36820
6 GRAPHIC image_006.jpg GRAPHIC 52761
7 GRAPHIC image_007.jpg GRAPHIC 43384
8 GRAPHIC caligan_logo.jpg GRAPHIC 18948
  Complete submission text file 0000902664-19-003718.txt   589460
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-10865 | Film No.: 191093806
SIC: 2834 Pharmaceutical Preparations

Mailing Address 520 MADISON AVENUE NEW YORK NY 10022
Business Address 520 MADISON AVENUE NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A